468 related articles for article (PubMed ID: 11773887)
1. The role of alphabeta- and gammadelta-T cells in allogenic donor marrow on engraftment, chimerism, and graft-versus-host disease.
Huang Y; Cramer DE; Ray MB; Chilton PM; Que X; Ildstad ST
Transplantation; 2001 Dec; 72(12):1907-14. PubMed ID: 11773887
[TBL] [Abstract][Full Text] [Related]
2. CD8(+), alphabeta-TCR(+), and gammadelta-TCR(+) cells in the recipient hematopoietic environment mediate resistance to engraftment of allogeneic donor bone marrow.
Xu H; Exner BG; Cramer DE; Tanner MK; Mueller YM; Ildstad ST
J Immunol; 2002 Feb; 168(4):1636-43. PubMed ID: 11823491
[TBL] [Abstract][Full Text] [Related]
3. T-cell depletion of allogeneic bone marrow using anti-alphabetaTCR monoclonal antibody: prevention of graft-versus-host disease without affecting engraftment potential in rats.
Neipp M; Exner BG; Maru D; Haber M; Gammie JS; Pham SM; Ildstad ST
Exp Hematol; 1999 May; 27(5):860-7. PubMed ID: 10340402
[TBL] [Abstract][Full Text] [Related]
4. A partial conditioning approach to achieve mixed chimerism in the rat: depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment.
Neipp M; Gammie JS; Exner BG; Li S; Chambers WH; Pham SM; Ildstad ST
Transplantation; 1999 Aug; 68(3):369-78. PubMed ID: 10459540
[TBL] [Abstract][Full Text] [Related]
5. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
6. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
Colson YL; Zadach K; Nalesnik M; Ildstad ST
Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
[TBL] [Abstract][Full Text] [Related]
7. Both gamma delta T cells and NK cells inhibit the engraftment of xenogeneic rat bone marrow cells and the induction of xenograft tolerance in mice.
Nikolic B; Cooke DT; Zhao G; Sykes M
J Immunol; 2001 Jan; 166(2):1398-404. PubMed ID: 11145725
[TBL] [Abstract][Full Text] [Related]
8. Dissociation between peripheral blood chimerism and tolerance to hindlimb composite tissue transplants: preferential localization of chimerism in donor bone.
Rahhal DN; Xu H; Huang WC; Wu S; Wen Y; Huang Y; Ildstad ST
Transplantation; 2009 Sep; 88(6):773-81. PubMed ID: 19920776
[TBL] [Abstract][Full Text] [Related]
9. Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease.
Gorantla VS; Prabhune KA; Perez-Abadia G; Ildstad ST; Maldonado C; Orhun HI; Majzoub RK; Francois CG; Kakoulidis TP; Brouha PC; Anderson GL; Pidwell DJ; Breidenbach WC; Barker JH
Transplantation; 2003 Apr; 75(7):922-32. PubMed ID: 12698075
[TBL] [Abstract][Full Text] [Related]
10. Donor gamma delta T lymphocytes promote allogeneic engraftment across the major histocompatibility barrier in mice.
Drobyski WR; Majewski D
Blood; 1997 Feb; 89(3):1100-9. PubMed ID: 9028343
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
[TBL] [Abstract][Full Text] [Related]
12. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation.
Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
J Surg Res; 2012 Nov; 178(1):487-93. PubMed ID: 22484382
[TBL] [Abstract][Full Text] [Related]
13. Multilineage engraftment with minimal graft-versus-host disease following in utero transplantation of S-59 psoralen/ultraviolet a light-treated, sensitized T cells and adult T cell-depleted bone marrow in fetal mice.
Bhattacharyya S; Chawla A; Smith K; Zhou Y; Talib S; Wardwell B; Cowan MJ
J Immunol; 2002 Dec; 169(11):6133-40. PubMed ID: 12444116
[TBL] [Abstract][Full Text] [Related]
14. Facilitating cells as a venue to establish mixed chimerism and tolerance.
Jacquet EG; Schanie CL; Fugier-Vivier I; Willer SS; Ildstad ST
Pediatr Transplant; 2003 Oct; 7(5):348-57. PubMed ID: 14738294
[TBL] [Abstract][Full Text] [Related]
15. Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation.
Kawanishi Y; Passweg J; Drobyski WR; Rowlings P; Cook-Craig A; Casper J; Pietryga D; Garbrecht F; Camitta B; Horowitz M; Juckett M; Margolis D; Flomenberg N; Keever-Taylor CA
Bone Marrow Transplant; 1997 Jun; 19(11):1069-77. PubMed ID: 9193748
[TBL] [Abstract][Full Text] [Related]
16. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
Chen B; Xu H; Corbin DR; Ildstad ST
Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444
[TBL] [Abstract][Full Text] [Related]
17. Alpha/beta T-cell depleted grafts as an immunological booster to treat graft failure after hematopoietic stem cell transplantation with HLA-matched related and unrelated donors.
Rådestad E; Wikell H; Engström M; Watz E; Sundberg B; Thunberg S; Uzunel M; Mattsson J; Uhlin M
J Immunol Res; 2014; 2014():578741. PubMed ID: 25371909
[TBL] [Abstract][Full Text] [Related]
18. Critical role of host gammadelta T cells in experimental acute graft-versus-host disease.
Maeda Y; Reddy P; Lowler KP; Liu C; Bishop DK; Ferrara JL
Blood; 2005 Jul; 106(2):749-55. PubMed ID: 15797996
[TBL] [Abstract][Full Text] [Related]
19. A Critical Role for TGF-β/Fc and Nonlytic IL-2/Fc Fusion Proteins in Promoting Chimerism and Donor-Specific Tolerance.
Xu H; Zheng XX; Zhang W; Huang Y; Ildstad ST
Transplantation; 2017 Feb; 101(2):294-301. PubMed ID: 27306533
[TBL] [Abstract][Full Text] [Related]
20. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.
Foster RD; Ascher NL; McCalmont TH; Neipp M; Anthony JP; Mathes SJ
Transplantation; 2001 Sep; 72(5):791-7. PubMed ID: 11571439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
